Daniel Goldstein, M.D. currently serves as lead, medical sciences and outreach & senior science fellow, at Monsanto Regulatory Affairs. He is involved in plant biotechnology, pesticide, and children’s health issues and has served on the EPA Child Health Protection Advisory Committee and the EPA Science Advisory Board (early-life exposure to carcinogens), as an advisor to the North American Free Trade Agreement Commission for Environmental Cooperation (child health indicators), and as a Leadership Council member, Biomonitoring Working Group member, and Chair of the Chemical Use and Exposure Pathways Sub-Group for the National Conversation on Public Health and Chemicals in the Environment. Dr. Goldstein has previously served on the Board of Directors of the American College of Medical Toxicology, and currently serves as a Science Advisor to the International Life Sciences Institute/Health and Environmental Sciences Institute, as a member of the Medical Toxicology Foundation Advisory Board, and as American Board of Pediatrics representative and Chair (2013-14) of the Conjoint Medical Toxicology Sub-Board, the examining and certification body for Medical Toxicology. Dr. Goldstein received a B.S. (Molecular Biology) from University of Wisconsin (1976) and an M.D. from Johns Hopkins (1981), followed by residency in Pediatrics (Johns Hopkins) and fellowship in Clinical Pharmacology and Medical Toxicology (University of Toronto). He is board certified by the American Boards of Pediatrics, Medical Toxicology, and Clinical Pharmacology, and by the Royal College of Physicians of Canada (Pediatrics). Dr. Goldstein is a fellow of the American Academy of Pediatrics and American College of Medical Toxicology.